Introduction:

Elderly constitute a population group with a predominance of chronic diseases, among them arterial hypertension. This implies an increase in drugs consumption and the problems related to them. Hence, in these the development of pharmaceutical care is useful for optimize the pharmacotherapy that they receive.

Objective:

To evaluate the impact of a pharmaceutical care service in hypertensive elderly patients.

Methods:

A prospective and intervention study was conducted from January to June 2017, with the participation of 50 hypertensive elderly patients. For the development of the service, a standard operating procedure was used. The impact of the service on therapeutic adherence, patient satisfaction and the resolution or prevention of negative outcomes associated with medication was evaluated.

Results:

Female patients predominated (62%) and pre-university level of education (40%). 54% of the patients were subjected to polypharmacy. 232 negative outcomes associated with medication were detected, predominantly safety (75.4%), followed by those of effectiveness (17.7%). There were 237 pharmaceutical interventions that increased the percentage of patients totally adherent to 84%. We resolved 82.76% of the negative outcomes associated with medication and 100% of the patients were satisfied with the service.

Conclusions:

The service developed had a high impact by increasing therapeutic adherence, solving most of the negative outcomes associated with medication and achieving the satisfaction of patients and caregivers.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )